Preclinical studies demonstrated that VEGF-driven angiogenesis leads to the expansion of suppressive immune cells including Tregs and MDSCs [59, 60] and increases tumor-associated macrophages’ (TAMs) infiltrates in tumor sites [61]. Here, VEGFA is linked to neoplasm.